组织学和细胞学市场－全球产业规模、份额、趋势、机会和预测，按检查类型、产品、应用、地区和竞争细分，2020-2030 年

2024 年全球组织学和细胞学市场价值为 173.7 亿美元，预计在预测期内将达到 366.1 亿美元，到 2030 年的复合年增长率为 13.19%。细胞学是生命科学的一个分支，涉及细胞的结构、功能和理解，而组织学则涉及生命形式细胞和组织的微观解剖结构。组织学和细胞学致力于解释动植物组织和细胞的结构，特别是在微观层面。细胞学因其检查速度快、精确性和价格合理，以及疾病盛行率高和用于子宫颈筛检的测试而广受欢迎。组织学和细胞学可以诊断许多传染性和细胞疾病，例如子宫颈疾病、发炎性疾病、癌症和自体免疫疾病。组织学和细胞学市场在医疗保健行业中经历了巨大的增长，因为许多疾病可以透过这些临床研究来诊断。借助组织学和细胞学，可以识别多种传染病，例如子宫颈疾病、癌症、异常生长、肝炎、发炎性疾病、腹泻、白血病、天花、狂犬病等。从商业角度来看，细胞学和组织学用于诊断和研究程序。市场趋势取决于製造商对这些临床程序的试剂和试剂盒开发的偏好。

数位病理学、人工智慧辅助成像和自动化切片製备等先进技术在诊断实验室的日益普及，进一步推动了全球组织学和细胞学市场的成长。这些创新技术提高了诊断准确性，减少了人为错误，并提升了工作流程效率。此外，远距病理学的整合使病理学家能够远端检查切片，这在农村或医疗资源匮乏的地区尤其有益，从而扩大了全球获得高品质诊断服务的管道。

关键市场驱动因素

癌症发生率不断上升

主要市场挑战

技术复杂性与成本

主要市场趋势

液体活检和循环生物标记

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球组织学与细胞学市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按检查类型（组织学、细胞学）
  • 按产品（仪器和分析软体系统、消耗品和试剂）
  • 按应用（药物发现与设计、临床诊断、研究）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
• 按考试类型
• 按产品
• 按应用
• 按地区

第六章：北美组织学与细胞学市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲组织学与细胞学市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太组织学与细胞学市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲组织学与细胞学市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲组织学和细胞学市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球组织学与细胞学市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Kimberly Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation.
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation.
• Trivitron Healthcare.
• Koninklijke Philips NV

第 16 章：策略建议

第17章调查会社について・免责事项

Global Histology and Cytology Market was valued at USD 17.37 billion in 2024 and is expected to reach USD 36.61 billion in the forecast period with a CAGR of 13.19% through 2030. Cytology is a branch of life science concerned with the structure, function, and understanding of cells, whereas histology is concerned with the microscopic anatomy of cells and tissues of life forms. Histology and cytology strive to explain the structure of animal and plant tissues and cells, particularly at the microscopic level. Cytology is quite popular due to its rapid examination rate, precision, and affordability, as well as the high disease prevalence and use of the test for cervix screening. The diagnosis of numerous infectious and cell-based disorders, such as cervical diseases, inflammatory diseases, cancer, and autoimmune diseases, is investigated using histology and cytology. The histology and cytology market has been witnessing massive growth in the healthcare industry as a number of diseases can be diagnosed through these clinical studies. With the aid of histology and cytology, a number of infectious diseases can be identified such as cervical disease, cancer, abnormal growth, hepatitis, inflammatory diseases, diarrhea, leukemia, smallpox, rabies etc. From the commercial perspective, cytology and histology are used in the diagnostic and research procedure. The market trends are determined along with the manufacturer's preference for the development of reagents and kits for these clinical procedures.

The increasing adoption of advanced technologies in diagnostic laboratories, such as digital pathology, AI-assisted imaging, and automated slide preparation, is further propelling the growth of the global histology and cytology market. These innovations enhance diagnostic accuracy, reduce manual errors, and improve workflow efficiency. Additionally, the integration of telepathology allows pathologists to remotely examine slides, which is especially beneficial in rural or underserved areas, thereby expanding access to high-quality diagnostics globally.

Key Market Drivers

Increasing prevalence of cancer

The rising global cancer burden is a major factor accelerating the growth of the Global Histology and Cytology Market. These medical disciplines, which focus on the microscopic examination of cells and tissues, are crucial for early and accurate cancer diagnosis. As cancer incidence continues to climb, particularly among aging populations, the demand for histopathological and cytological evaluations is growing rapidly. According to the International Agency for Research on Cancer (IARC), in 2022 there were approximately 20 million new cancer cases and 9.7 million cancer-related deaths globally figures expected to increase substantially in the coming decades.

Furthermore, the number of cancer screening procedures is rising, particularly in emerging economies with expanding healthcare infrastructure. Cytological methods such as the Pap smear remain essential for cervical cancer screening. According to the World Health Organization (WHO), over 90% of cervical cancer cases are preventable and treatable if detected early and managed appropriately placing histology and cytology at the heart of global cancer control strategies. The increased use of biopsy techniques to assess tumors has also led to a surge in histopathological evaluations, further driving market demand. Combined with advances in digital pathology, AI-powered diagnostics, and molecular cytology, these trends ensure strong growth for histology and cytology technologies in oncology.

In addition to diagnostics, the role of histology and cytology in therapeutic monitoring is gaining prominence. As more cancer patients undergo treatments like chemotherapy, immunotherapy, or targeted therapy, regular assessment of tissue samples helps monitor treatment response and detect any recurrence or resistance. This has fueled the integration of advanced cytological imaging systems and histological staining technologies in clinical laboratories and hospitals. The demand for accurate pathological interpretation has also led to growing collaborations between hospitals and diagnostic centers, further expanding access to histology and cytology services.

Key Market Challenges

Technological Complexity and Costs

Advanced histology and cytology technologies often require significant upfront investments in terms of equipment, software, training, and infrastructure. This can be a barrier for smaller clinics, hospitals, and research facilities with limited financial resources. The high initial investment can lead to slower adoption rates, especially in regions with budget constraints. Utilizing complex histology and cytology technologies requires a skilled workforce with specialized training. Training pathologists, technicians, and clinicians to effectively use and interpret data from these technologies can be time-consuming and costly. The scarcity of skilled personnel can further impede technology adoption. Technologically advanced equipment typically requires regular maintenance and updates to ensure optimal performance. The costs associated with maintenance, repairs, and software updates can add to the overall expenses for healthcare institutions. This ongoing financial commitment can be a deterrent, particularly for smaller facilities. Integrating new technology into existing healthcare systems and workflows can be challenging. Compatibility issues with existing systems and processes may arise, requiring additional investments in software development and integration solutions. These challenges can delay technology implementation and adoption.

Key Market Trends

Liquid Biopsies and Circulating Biomarkers

Liquid biopsies involve the analysis of biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs), present in blood or other bodily fluids. They enable early detection of diseases, including cancer, even before traditional symptoms manifest. This capability drives the demand for histology and cytology services that can identify and analyze these biomarkers accurately. Unlike traditional tissue biopsies, which require invasive procedures, liquid biopsies are minimally invasive. This approach reduces patient discomfort, risk, and recovery time. As liquid biopsies gain prominence, the demand for traditional histological and cytological procedures might decline for certain applications, but histology and cytology techniques are still essential for validating liquid biopsy results and providing comprehensive diagnoses. Liquid biopsies are often used in conjunction with traditional histology and cytology techniques. They can provide additional information about tumor heterogeneity, genetic mutations, and treatment responses that might not be apparent through tissue biopsies alone. The integration of liquid biopsy data enhances the overall diagnostic accuracy and treatment decision-making process. Circulating biomarkers provide valuable information about a patient's tumor characteristics, enabling the development of personalized treatment strategies. This demand for personalized medicine supports the growth of the histology and cytology market, as these techniques remain essential for understanding tissue-level details and providing comprehensive patient care.

Key Market Players

• Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation.
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation.
• Trivitron Healthcare.
• Koninklijke Philips N.V.

Report Scope:

In this report, the Global Histology and Cytology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Histology and Cytology Market, By Type of Examination:

• Histology
• Cytology

Histology and Cytology Market, By Product:

• Instruments and Analysis Software System
• Consumable and Reagents

Histology and Cytology Market, By Application:

• Drug Discovery & Designing
• Clinical Diagnostics
• Research

Histology and Cytology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Histology and Cytology Market.

Available Customizations:

Global Histology and Cytology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Histology and Cytology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type Of Examination (Histology, Cytology)
  • 5.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 5.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Type of Examination
• 5.3.2 By Product
• 5.3.3 By Application
• 5.3.4 By Region

6. North America Histology and Cytology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type Of Examination (Histology, Cytology)
  • 6.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 6.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Histology and Cytology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Examination
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Histology and Cytology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Examination
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Histology and Cytology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Examination
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Histology and Cytology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type Of Examination (Histology, Cytology)
  • 7.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 7.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Histology and Cytology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Examination
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Histology and Cytology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Examination
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Histology and Cytology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Examination
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Histology and Cytology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Examination
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Histology and Cytology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Examination
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia-Pacific Histology and Cytology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type Of Examination (Histology, Cytology)
  • 8.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 8.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Histology and Cytology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Examination
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Histology and Cytology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Examination
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Histology and Cytology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Examination
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Histology and Cytology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Examination
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Histology and Cytology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Examination
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. South America Histology and Cytology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type Of Examination (Histology, Cytology)
  • 9.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 9.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Histology and Cytology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Examination
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Histology and Cytology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Examination
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Histology and Cytology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Examination
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. Middle East and Africa Histology and Cytology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type Of Examination (Histology, Cytology)
  • 10.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 10.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Histology and Cytology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Examination
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Histology and Cytology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Examination
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Histology and Cytology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Examination
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Histology And Cytology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Kimberly Hologic, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. F Hoffmann-La Roche AG.
• 15.3. Abbott Laboratories Inc.
• 15.4. Becton Dickinson & Co.
• 15.5. Danaher Corporation.
• 15.6. Merck KGaA.
• 15.7. Thermo Fisher Scientific, Inc.
• 15.8. Sysmex Corporation.
• 15.9. Trivitron Healthcare.
• 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer